- Home
- Healthcare
- Alzheimer\'s Disease Diagnostic Market

Alzheimer\'s Disease Diagnostic Market Size, Share, Growth, and Market Analysis By Type (Genetic Testing, Neurological Exam, Mini-Mental State Exam (MMSE), Brain Imaging, Other), By End User (Clinics, Hospitals, Diagnostic Centers, Other), and Regional Forecast to 2033
Region: Global | Format: PDF | Report ID: PMI3165 | SKU ID: 29555836 | Pages: 105 | Published : July, 2025 | Base Year: 2024 | Historical Data: 2020 - 2023
Detailed TOC of Global Alzheimer's Disease Diagnostic Industry Trends Analysis Report 2025, Forecast to 2033 (Broken Down by Type, End User, Regional Analysis, and Competitive Landscape)
Table of Content_x000D_
_x000D_
1 Market Overview_x000D_
1.1 Product Definition and Market Characteristics_x000D_
1.2 Global Alzheimer's Disease Diagnostic Market Size_x000D_
1.3 Market Segmentation_x000D_
1.4 Regulatory Environment_x000D_
_x000D_
2 Industry Chain Analysis_x000D_
2.1 Industry Chain Analysis_x000D_
2.2 Alzheimer's Disease Diagnostic Raw Materials Analysis_x000D_
2.2.1 Key Raw Materials Introduction_x000D_
2.2.2 Key Suppliers of Raw Materials_x000D_
2.3 Alzheimer's Disease Diagnostic Business Mode and Production Process_x000D_
2.3.1 Alzheimer's Disease Diagnostic Business Mode Analysis_x000D_
2.3.2 Production Process Analysis_x000D_
2.4 Alzheimer's Disease Diagnostic Cost Structure Analysis_x000D_
2.4.1 Manufacturing Cost Structure of Alzheimer's Disease Diagnostic_x000D_
2.4.2 Raw Material Cost of Alzheimer's Disease Diagnostic_x000D_
2.4.3 Labor Cost of Alzheimer's Disease Diagnostic_x000D_
2.5 Market Channel Analysis_x000D_
2.6 Major Downstream Customers Analysis_x000D_
2.7 Alternative Product Analysis_x000D_
_x000D_
3 Market Dynamics_x000D_
3.1 Market Drivers_x000D_
3.2 Market Constraints and Challenges_x000D_
3.3 Emerging Market Trends_x000D_
3.4 PESTEL Analysis_x000D_
3.5 Consumer Insights Analysis_x000D_
3.6 Impact of Russia and Ukraine War_x000D_
_x000D_
4 Market Competitive Landscape_x000D_
4.1 Global Alzheimer's Disease Diagnostic Revenue and Market Share by Manufacturer (2020-2025)_x000D_
4.2 Global Alzheimer's Disease Diagnostic Sales Volume and Market Share by Manufacturer (2020-2025)_x000D_
4.3 Global Alzheimer's Disease Diagnostic Price by Manufacturer (2020-2025)_x000D_
4.4 Alzheimer's Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)_x000D_
4.5 Global Key Manufacturers of Alzheimer's Disease Diagnostic, Manufacturing Base Distribution and Headquarters_x000D_
4.6 Global Key Manufacturers of Alzheimer's Disease Diagnostic, Product Offered and Application_x000D_
4.7 Alzheimer's Disease Diagnostic Market Competitive Situation and Trends_x000D_
4.7.1 Alzheimer's Disease Diagnostic Market Concentration Rate_x000D_
4.7.2 Global Top 3 and Top 6 Alzheimer's Disease Diagnostic Players Market Share by Revenue_x000D_
4.8 Industry News_x000D_
4.8.1 Key Product Launch News_x000D_
4.8.2 Mergers & Acquisitions, Expansion Plans_x000D_
_x000D_
5 Global Alzheimer's Disease Diagnostic Market Historical Development by Geographic Region (2020-2025)_x000D_
5.1 Global Alzheimer's Disease Diagnostic Market Historical Sales Volume by Geographic Region (2020-2025)_x000D_
5.2 Global Alzheimer's Disease Diagnostic Market Historical Revenue by Geographic Region (2020-2025)_x000D_
5.3 North America Alzheimer's Disease Diagnostic Market Status by Country (2020-2025)_x000D_
5.3.1 North America Alzheimer's Disease Diagnostic Sales Volume by Country (2020-2025)_x000D_
5.3.2 North America Alzheimer's Disease Diagnostic Revenue by Country (2020-2025)_x000D_
5.3.3 United States Alzheimer's Disease Diagnostic Sales Volume, Revenue and Growth (2020-2025)_x000D_
5.3.4 Canada Alzheimer's Disease Diagnostic Sales Volume, Revenue and Growth (2020-2025)_x000D_
5.4 Europe Alzheimer's Disease Diagnostic Market Status by Country (2020-2025)_x000D_
5.4.1 Europe Alzheimer's Disease Diagnostic Sales Volume by Country (2020-2025)_x000D_
5.4.2 Europe Alzheimer's Disease Diagnostic Revenue by Country (2020-2025)_x000D_
5.4.3 Germany Alzheimer's Disease Diagnostic Sales Volume, Revenue and Growth (2020-2025)_x000D_
5.4.4 France Alzheimer's Disease Diagnostic Sales Volume, Revenue and Growth (2020-2025)_x000D_
5.4.5 United Kingdom Alzheimer's Disease Diagnostic Sales Volume, Revenue and Growth (2020-2025)_x000D_
5.4.6 Spain Alzheimer's Disease Diagnostic Sales Volume, Revenue and Growth (2020-2025)_x000D_
5.4.7 Russia Alzheimer's Disease Diagnostic Sales Volume, Revenue and Growth (2020-2025)_x000D_
5.4.8 Poland Alzheimer's Disease Diagnostic Sales Volume, Revenue and Growth (2020-2025)_x000D_
5.5 Asia Pacific Alzheimer's Disease Diagnostic Market Status by Country (2020-2025)_x000D_
5.5.1 Asia Pacific Alzheimer's Disease Diagnostic Sales Volume by Country (2020-2025)_x000D_
5.5.2 Asia Pacific Alzheimer's Disease Diagnostic Revenue by Country (2020-2025)_x000D_
5.5.3 China Alzheimer's Disease Diagnostic Sales Volume, Revenue and Growth (2020-2025)_x000D_
5.5.4 Japan Alzheimer's Disease Diagnostic Sales Volume, Revenue and Growth (2020-2025)_x000D_
5.5.5 South Korea Alzheimer's Disease Diagnostic Sales Volume, Revenue and Growth (2020-2025)_x000D_
5.5.6 Southeast Asia Alzheimer's Disease Diagnostic Sales Volume, Revenue and Growth (2020-2025)_x000D_
5.5.7 India Alzheimer's Disease Diagnostic Sales Volume, Revenue and Growth (2020-2025)_x000D_
5.5.8 Australia Alzheimer's Disease Diagnostic Sales Volume, Revenue and Growth (2020-2025)_x000D_
5.6 Latin America Alzheimer's Disease Diagnostic Market Status by Country (2020-2025)_x000D_
5.6.1 Latin America Alzheimer's Disease Diagnostic Sales Volume by Country (2020-2025)_x000D_
5.6.2 Latin America Alzheimer's Disease Diagnostic Revenue by Country (2020-2025)_x000D_
5.6.3 Mexico Alzheimer's Disease Diagnostic Sales Volume, Revenue and Growth (2020-2025)_x000D_
5.6.4 Brazil Alzheimer's Disease Diagnostic Sales Volume, Revenue and Growth (2020-2025)_x000D_
5.7 Middle East and Africa Alzheimer's Disease Diagnostic Market Status by Country (2020-2025)_x000D_
5.7.1 Middle East and Africa Alzheimer's Disease Diagnostic Sales Volume by Country (2020-2025)_x000D_
5.7.2 Middle East and Africa Alzheimer's Disease Diagnostic Revenue by Country (2020-2025)_x000D_
5.7.3 GCC Alzheimer's Disease Diagnostic Sales Volume, Revenue and Growth (2020-2025)_x000D_
5.7.4 South Africa Alzheimer's Disease Diagnostic Sales Volume, Revenue and Growth (2020-2025)_x000D_
_x000D_
6 Global Alzheimer's Disease Diagnostic Market Historical Development by Product Type (2020-2025)_x000D_
6.1 Alzheimer's Disease Diagnostic Definition by Type_x000D_
6.2 Global Alzheimer's Disease Diagnostic Historical Sales Volume by Product Type (2020-2025)_x000D_
6.3 Global Alzheimer's Disease Diagnostic Historical Revenue by Product Type (2020-2025)_x000D_
6.4 Global Alzheimer's Disease Diagnostic Historical Price by Product Type (2020-2025)_x000D_
6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2020-2025)_x000D_
6.5.1 Global Alzheimer's Disease Diagnostic Historical Sales Volume, Revenue and Growth Rate of Genetic Testing (2020-2025)
6.5.2 Global Alzheimer's Disease Diagnostic Historical Sales Volume, Revenue and Growth Rate of Neurological Exam (2020-2025)
6.5.3 Global Alzheimer's Disease Diagnostic Historical Sales Volume, Revenue and Growth Rate of Mini-Mental State Exam (MMSE) (2020-2025)
6.5.4 Global Alzheimer's Disease Diagnostic Historical Sales Volume, Revenue and Growth Rate of Brain Imaging (2020-2025)
6.5.5 Global Alzheimer's Disease Diagnostic Historical Sales Volume, Revenue and Growth Rate of Other (2020-2025)
_x000D_
7 Global Alzheimer's Disease Diagnostic Market Historical Development by End User (2020-2025)_x000D_
7.1 Downstream Market Overview_x000D_
7.2 Global Alzheimer's Disease Diagnostic Historical Sales Volume by End User (2020-2025)_x000D_
7.3 Global Alzheimer's Disease Diagnostic Historical Revenue by End User (2020-2025)_x000D_
7.4 Global Alzheimer's Disease Diagnostic Historical Price by End User (2020-2025)_x000D_
7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2020-2025)_x000D_
7.5.1 Global Alzheimer's Disease Diagnostic Historical Sales Volume, Revenue and Growth Rate of Clinics (2020-2025)
7.5.2 Global Alzheimer's Disease Diagnostic Historical Sales Volume, Revenue and Growth Rate of Hospitals (2020-2025)
7.5.3 Global Alzheimer's Disease Diagnostic Historical Sales Volume, Revenue and Growth Rate of Diagnostic Centers (2020-2025)
7.5.4 Global Alzheimer's Disease Diagnostic Historical Sales Volume, Revenue and Growth Rate of Other (2020-2025)
_x000D_
8 Leading Companies Profiles_x000D_
8.1 Treventis
8.1.1 Treventis Corporation Information
8.1.2 Treventis - Alzheimer's Disease Diagnostic Product Portfolio and Specification
8.1.3 Treventis Performance Analysis (2020-2025)
8.1.4 Treventis Business and Markets Served
8.1.5 Treventis Recent Developments
8.2 TauRx
8.2.1 TauRx Corporation Information
8.2.2 TauRx - Alzheimer's Disease Diagnostic Product Portfolio and Specification
8.2.3 TauRx Performance Analysis (2020-2025)
8.2.4 TauRx Business and Markets Served
8.2.5 TauRx Recent Developments
8.3 Cognition Therapeutics
8.3.1 Cognition Therapeutics Corporation Information
8.3.2 Cognition Therapeutics - Alzheimer's Disease Diagnostic Product Portfolio and Specification
8.3.3 Cognition Therapeutics Performance Analysis (2020-2025)
8.3.4 Cognition Therapeutics Business and Markets Served
8.3.5 Cognition Therapeutics Recent Developments
8.4 Accera
8.4.1 Accera Corporation Information
8.4.2 Accera - Alzheimer's Disease Diagnostic Product Portfolio and Specification
8.4.3 Accera Performance Analysis (2020-2025)
8.4.4 Accera Business and Markets Served
8.4.5 Accera Recent Developments
8.5 Alector
8.5.1 Alector Corporation Information
8.5.2 Alector - Alzheimer's Disease Diagnostic Product Portfolio and Specification
8.5.3 Alector Performance Analysis (2020-2025)
8.5.4 Alector Business and Markets Served
8.5.5 Alector Recent Developments
8.6 Neuro-Bio
8.6.1 Neuro-Bio Corporation Information
8.6.2 Neuro-Bio - Alzheimer's Disease Diagnostic Product Portfolio and Specification
8.6.3 Neuro-Bio Performance Analysis (2020-2025)
8.6.4 Neuro-Bio Business and Markets Served
8.6.5 Neuro-Bio Recent Developments
8.7 Eli Lilly
8.7.1 Eli Lilly Corporation Information
8.7.2 Eli Lilly - Alzheimer's Disease Diagnostic Product Portfolio and Specification
8.7.3 Eli Lilly Performance Analysis (2020-2025)
8.7.4 Eli Lilly Business and Markets Served
8.7.5 Eli Lilly Recent Developments
_x000D_
9 Global Alzheimer's Disease Diagnostic Market Forecast by Product Type and End User (2025-2033)_x000D_
9.1 Global Alzheimer's Disease Diagnostic Market Forecast by Product Type (2025-2033)_x000D_
9.1.1 Global Alzheimer's Disease Diagnostic Sales Volume, Revenue Forecast and Growth Rate of Genetic Testing (2025-2033)
9.1.2 Global Alzheimer's Disease Diagnostic Sales Volume, Revenue Forecast and Growth Rate of Neurological Exam (2025-2033)
9.1.3 Global Alzheimer's Disease Diagnostic Sales Volume, Revenue Forecast and Growth Rate of Mini-Mental State Exam (MMSE) (2025-2033)
9.1.4 Global Alzheimer's Disease Diagnostic Sales Volume, Revenue Forecast and Growth Rate of Brain Imaging (2025-2033)
9.1.5 Global Alzheimer's Disease Diagnostic Sales Volume, Revenue Forecast and Growth Rate of Other (2025-2033)
9.2 Global Alzheimer's Disease Diagnostic Market Forecast by End User (2025-2033)_x000D_
9.2.1 Global Alzheimer's Disease Diagnostic Sales Volume, Revenue Forecast and Growth Rate of Clinics (2025-2033)
9.2.2 Global Alzheimer's Disease Diagnostic Sales Volume, Revenue Forecast and Growth Rate of Hospitals (2025-2033)
9.2.3 Global Alzheimer's Disease Diagnostic Sales Volume, Revenue Forecast and Growth Rate of Diagnostic Centers (2025-2033)
9.2.4 Global Alzheimer's Disease Diagnostic Sales Volume, Revenue Forecast and Growth Rate of Other (2025-2033)
_x000D_
10 Global Alzheimer's Disease Diagnostic Market Forecast by Geographic Region (2025-2033)_x000D_
10.1 Global Alzheimer's Disease Diagnostic Sales Volume and Revenue Forecast by Geographic Region (2025-2033)_x000D_
10.2 North America Alzheimer's Disease Diagnostic Sales Volume, Revenue Forecast and Growth (2025-2033)_x000D_
10.2.1 United States Alzheimer's Disease Diagnostic Sales Volume, Revenue Forecast and Growth (2025-2033)_x000D_
10.2.2 Canada Alzheimer's Disease Diagnostic Sales Volume, Revenue Forecast and Growth (2025-2033)_x000D_
10.3 Europe Alzheimer's Disease Diagnostic Sales Volume, Revenue Forecast and Growth (2025-2033)_x000D_
10.3.1 Germany Alzheimer's Disease Diagnostic Sales Volume, Revenue Forecast and Growth (2025-2033)_x000D_
10.3.2 France Alzheimer's Disease Diagnostic Sales Volume, Revenue Forecast and Growth (2025-2033)_x000D_
10.3.3 United Kingdom Alzheimer's Disease Diagnostic Sales Volume, Revenue Forecast and Growth (2025-2033)_x000D_
10.3.4 Spain Alzheimer's Disease Diagnostic Sales Volume, Revenue Forecast and Growth (2025-2033)_x000D_
10.3.5 Russia Alzheimer's Disease Diagnostic Sales Volume, Revenue Forecast and Growth (2025-2033)_x000D_
10.3.6 Poland Alzheimer's Disease Diagnostic Sales Volume, Revenue Forecast and Growth (2025-2033)_x000D_
10.4 Asia Pacific Alzheimer's Disease Diagnostic Sales Volume, Revenue Forecast and Growth (2025-2033)_x000D_
10.4.1 China Alzheimer's Disease Diagnostic Sales Volume, Revenue Forecast and Growth (2025-2033)_x000D_
10.4.2 Japan Alzheimer's Disease Diagnostic Sales Volume, Revenue Forecast and Growth (2025-2033)_x000D_
10.4.3 South Korea Alzheimer's Disease Diagnostic Sales Volume, Revenue Forecast and Growth (2025-2033)_x000D_
10.4.4 Southeast Asia Alzheimer's Disease Diagnostic Sales Volume, Revenue Forecast and Growth (2025-2033)_x000D_
10.4.5 India Alzheimer's Disease Diagnostic Sales Volume, Revenue Forecast and Growth (2025-2033)_x000D_
10.4.6 Australia Alzheimer's Disease Diagnostic Sales Volume, Revenue Forecast and Growth (2025-2033)_x000D_
10.5 Latin America Alzheimer's Disease Diagnostic Sales Volume, Revenue Forecast and Growth (2025-2033)_x000D_
10.5.1 Mexico Alzheimer's Disease Diagnostic Sales Volume, Revenue Forecast and Growth (2025-2033)_x000D_
10.5.2 Brazil Alzheimer's Disease Diagnostic Sales Volume, Revenue Forecast and Growth (2025-2033)_x000D_
10.6 Middle East and Africa Alzheimer's Disease Diagnostic Sales Volume, Revenue Forecast and Growth (2025-2033)_x000D_
10.6.1 GCC Alzheimer's Disease Diagnostic Sales Volume, Revenue Forecast and Growth (2025-2033)_x000D_
10.6.2 South Africa Alzheimer's Disease Diagnostic Sales Volume, Revenue Forecast and Growth (2025-2033)_x000D_
_x000D_
11 Appendix_x000D_
11.1 Methodology_x000D_
11.2 Research Data Source_x000D_
11.2.1 Secondary Data_x000D_
11.2.2 Primary Data_x000D_
11.2.3 Market Size Estimation_x000D_
11.2.4 Legal Disclaimer_x000D_
_x000D_